International Psychometric Validation Study of the Intestinal Gas Questionnaire (IGQ)

NCT03002584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-02-18

No results posted yet for this study

Summary

Objective: To confirm the psychometrics properties of the Intestinal Gas Questionnaire (IGQ) in subjects with Irritable Bowel Syndrome (IBS) diagnosis and General population both complaining of Gas-Related Symptoms (GRS).

IGQ has been developed previously simultaneously in UK English, French and Spanish through qualitative research with subject interviews. The conceptual framework of the IGQ assesses both GRS and their impact on daily life. Similar concepts were identified for both subjects with IBS diagnosis and general population and complaining of gas-related symptoms.

The IGQ consists of a 24-hour recall symptom diary assessing 7 gas-related symptoms (17 items) and a 7-day recall questionnaire which assesses the impact of those symptoms (26 items)

Conditions

  • IBS - Irritable Bowel Syndrome
  • General Population

Interventions

OTHER

completion of self-reported questionnaires

Single completion: Participants will have to complete the IGQ, the generic health status EQ-5D questionnaire, the specific FDDQL questionnaire (Functional Digestive Disorders Quality of Life). Test-retest: during the second completion within a mean 7-day interval, participants will complete the IGQ and a single global Gastro-Intestinal Well-Being scale

Sponsors & Collaborators

  • EA 7334, Patient-Centered Outcomes Research

    collaborator UNKNOWN
  • University of Manchester

    collaborator OTHER
  • Hospital Vall d'Hebron

    collaborator OTHER
  • Hôpital Louis Mourier

    collaborator OTHER
  • University Paris 7 - Denis Diderot

    lead OTHER

Principal Investigators

  • Olivier Chassany, MD, PhD · EA 7334, University Paris-Diderot, Paris

  • Peter Whorwell, MD, PhD · university of Manchester, Manchester

  • Fernando Azpiroz, MD, PhD · Hospital Vall d'Hebron, Barcelona

  • Benoit Coffin, MD, PhD · Hopital Louis Mourier, Colombes

  • Martin Duracinsky, MD, PhD · EA 7334, University Paris-Diderot, Paris

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-10
Primary Completion
2018-04-30
Completion
2018-07-10

Countries

  • France
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03002584 on ClinicalTrials.gov